Author

Daichi Yamasoba

Institute of Medical Science, The University of Tokyo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1 Organism:virus· 1

Frequent Co-Authors

Hiroyuki AsakuraiD· 2 shared Jumpei ItoiD· 2 shared Kazuhisa YoshimuraiD· 2 shared Kei SatoiD· 2 shared Keiya Uriu· 2 shared Kenji SadamasuiD· 2 shared Mami NagashimaiD· 2 shared Yu KakuiD· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Hiroyuki AsakuraORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyThe Lancet Infectious DiseasesPeer-reviewedMay 20, 2024

Virological characteristics of the SARS-CoV-2 KP.2 variant

Yu Kaku, Keiya Uriu, Yusuke Kosugi…·Kei Sato

This study investigates the virological properties of the SARS-CoV-2 KP.2 variant, finding it has higher viral fitness and immune resistance compared to JN.1, contributing to its rapid spread.

100 citationstop 1%

virusstatistical model

𝕏 PostBluesky

MicrobiologyNature CommunicationsPeer-reviewedFeb 8, 2024

Virological characteristics of the SARS-CoV-2 XBB.1.5 variant

Tomokazu Tamura, Takashi Irie, Sayaka Deguchi…·Takasuke Fukuhara

The paper analyzes the virological characteristics of the SARS-CoV-2 XBB.1.5 variant, showing reduced pathogenicity and impaired MHC expression due to mutations in ORF8 and S.

109 citationstop 1%

humanexperimental assay

𝕏 PostBluesky